Optimizing Y90 Therapy for Radiation Lobectomy
NCT: NCT04390724 · ACTIVE_NOT_RECRUITING
広告
NCT識別子NCT04390724
ステータスACTIVE_NOT_RECRUITING
開始日2020-07-17
完了2026-11-27
SponsorNorthwestern University (OTHER)
First posted
Last updated
概要
HCC resection candidates with inadequate future liver remnant will be enrolled in this study. They will be treated with Y90 radioembolization to help grow the liver enough to undergo liver resection. There will be 2 Patient Groups. The first group of patients will be treated with Y90 dose and embolic load as per standard-of-care. The second group of patients will be treated with the optimal Y90 dose and embolic load found in Patient Group 1.
公式ソース
ClinicalTrials.govで見る →データはClinicalTrials.gov APIから取得しています。最新のステータスは公式記録をご確認ください。